Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Investigation

• Publication date

  2013-12-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI66271PMID 24200690PMCID PMC3859391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disruption of sarcolemmal dystrophin and β-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis

  2010cited by this paper
• Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy

  2010cited by this paper
• Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study

  2010cited by this paper
• Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart.

  2008cited by this paper
• Recognition memory and the medial temporal lobe: a new perspective

  2007cited by this paper
• Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure.

  2007cited by this paper
• Cardiomyopathy Associated with Microcirculation Dysfunction in Laminin α4 Chain-deficient Mice*

  2006cited by this paper
• Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy

  2006influential reference
• Differential Cleavage of eIF4GI and eIF4GII in Mammalian Cells

  2006cited by this paper
• The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.

  2004cited by this paper
• Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: A genetic predisposition to viral heart disease

  2002cited by this paper
• Enteroviral Protease 2A Directly Cleaves Dystrophin and Is Inhibited by a Dystrophin-based Substrate Analogue*

  2000cited by this paper
• Investigation

  2000cited by this paper
• Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations

  2000cited by this paper
• Dissociation of Sarcoglycans and the Dystrophin Carboxyl Terminus From the Sarcolemma in Enteroviral Cardiomyopathy

  2000cited by this paper
• Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy

  1999cited by this paper
• A Novel Functional Human Eukaryotic Translation Initiation Factor 4G

  1998cited by this paper
• Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.

  1997cited by this paper
• Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus.

  1993cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper
• Intracellular calcium accumulation in Duchenne dystrophy and other myopathies

  1978cited by this paper

• Unbiased cleavage site prediction uncovers viral antagonism of host innate immunity by SARS-CoV-2 3C-like protease.

  2026influential citation
• Genomics of pediatric cardiomyopathy

  2025cites this paper
• Cardiomyopathy-Associated Pathogenic Variants in Pediatric Myocarditis: A Study From the Pediatric Cardiomyopathy Registry.

  2025cites this paper
• Diffuse Active Myocarditis in a Teenager with Duchenne Muscular Dystrophy - a case report

  2025cites this paper
• Viral Infection and Connexin Dysfunction in the Heart

  2025cites this paper
• Acute adenoviral infection elicits an arrhythmogenic substrate prior to myocarditis

  2024cites this paper
• SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation

  2024cites this paper
• Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model

  2024cites this paper
• Mechanistic insights into bone remodelling dysregulation by human viral pathogens

  2024cites this paper
• In Silico Screening of Inhibitors of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease

  2023cites this paper
• Automated SSHHPS Analysis Predicts a Potential Host Protein Target Common to Several Neuroinvasive (+)ssRNA Viruses

  2023cites this paper
• Mitochondria Dysfunction at the Heart of Viral Myocarditis: Mechanistic Insights and Therapeutic Implications

  2023cites this paper
• Early Emergence of 5′ Terminally Deleted Coxsackievirus-B3 RNA Forms Is Associated with Acute and Persistent Infections in Mouse Target Tissues

  2022cites this paper
• Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis

  2022cites this paper
• Immunohistochemical Detection of Enteroviruses in Pancreatic Tissues of Patients with Type 1 Diabetes Using a Polyclonal Antibody Against 2A Protease of Coxsackievirus

  2021cites this paper
• Immunohistochemical detection of enteroviruses in pancreatic tissues of patients with type 1 diabetes using a polyclonal antibody against 2A protease of Coxsackievirus

  2021cites this paper
• Burden of Cardiomyopathic Genetic Variation in Lethal Pediatric Myocarditis

  2021cites this paper
• Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?

  2021cites this paper
• The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease

  2021cites this paper
• Coxsackievirus B3—Its Potential as an Oncolytic Virus

  2021cites this paper
• Multiplexed High-Throughput Serological Assay for Human Enteroviruses

  2020cites this paper
• Recognition and Initial Management of Fulminant Myocarditis

  2020cites this paper
• Genetic Basis and Molecular Biology of Cardiac Arrhythmias in Cardiomyopathies.

  2020cites this paper
• Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus

  2020cites this paper
• Role of coxsackie‐adenovirus receptor in cardiac development and pathogenesis of congenital heart disease

  2020cites this paper
• Essential roles of the dystrophin-glycoprotein complex in different cardiac pathologies.

  2020cites this paper
• The use of magnetic targeting for drug delivery into cardiac myocytes

  2019cites this paper
• Specific elimination of coxsackievirus B3 infected cells with a protein engineered toxin-antitoxin system

  2019cites this paper
• miR-486 is modulated by stretch and increases ventricular growth

  2019cites this paper
• Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.

  2019cites this paper
• Enterovirus persistence in cardiac cells of patients suffering from idiopathic dilated cardiomyopathy is linked to 5’ terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities

  2019cites this paper
• and RNA Metabolism: Local and Global Effects of

  2019cites this paper
• New Coxsackievirus 2Apro and 3Cpro protease antibodies for virus detection and discovery of pathogenic mechanisms.

  2018cites this paper
• The development of coxsackievirus type B3 as a novel oncolytic virus against KRAS-mutant non-small-cell lung cancer

  2018cites this paper
• Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis.

  2017cites this paper
• Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins

  2017cites this paper
• Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects

  2017cites this paper
• Viral Heart Disease

  2017cites this paper
• Myocarditis: An Intersection Between Genetic and Acquired Causes of Human Cardiomyopathy.

  2017cites this paper
• Functional Consequences of RNA 5′-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation

  2017cites this paper
• Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis.

  2016cites this paper
• Enteroviral proteases: structure, host interactions and pathogenicity

  2016cites this paper
• Connecting enterovirus infection to dystrophin dysfunction in dilated cardiomyopathy.

  2016cites this paper
• Increased Echogenicity and Radiodense Foci on Echocardiogram and MicroCT in Murine Myocarditis

  2016cites this paper
• Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A–mediated C-terminal dystrophin cleavage fragment

  2015influential citation
• Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis.

  2015cites this paper
• Coxsackievirus B3 replication and pathogenesis.

  2015cites this paper
• Enhanced enteroviral infectivity via viral protease‐mediated cleavage of Grb2‐associated binder 1

  2015cites this paper
• Cyclic stretch of embryonic cardiomyocytes increases proliferation, growth, and expression while repressing Tgf-β signaling.

  2015cites this paper
• Use of the 5' untranslated region and VP1 region to examine the molecular diversity in enterovirus B species.

  2014cites this paper
• Uncleaved Dystrophin Induce Cardiac Myocyte Apoptosis in Coxsackievirus Infected Balb/C Background Mice Heart

  2014cites this paper
• Finding the Sweet Spot: Assembly and Glycosylation of the Dystrophin‐Associated Glycoprotein Complex

  2014influential citation